US20140256989A1 - Process for the preparation of hydroxytyrosol - Google Patents
Process for the preparation of hydroxytyrosol Download PDFInfo
- Publication number
- US20140256989A1 US20140256989A1 US14/188,837 US201414188837A US2014256989A1 US 20140256989 A1 US20140256989 A1 US 20140256989A1 US 201414188837 A US201414188837 A US 201414188837A US 2014256989 A1 US2014256989 A1 US 2014256989A1
- Authority
- US
- United States
- Prior art keywords
- compound
- formula
- radical
- acid
- hydroxytyrosol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 title claims abstract description 93
- 235000003248 hydroxytyrosol Nutrition 0.000 title claims abstract description 46
- 229940095066 hydroxytyrosol Drugs 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims description 45
- 238000002360 preparation method Methods 0.000 title description 10
- -1 C1-C8 alkyl radical Chemical class 0.000 claims abstract description 43
- 150000001875 compounds Chemical class 0.000 claims abstract description 41
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000007864 aqueous solution Substances 0.000 claims abstract description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 6
- 239000003929 acidic solution Substances 0.000 claims abstract description 5
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000001257 hydrogen Substances 0.000 claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 4
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 4
- 150000005840 aryl radicals Chemical class 0.000 claims abstract description 3
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 3
- 229910052744 lithium Inorganic materials 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract description 3
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 18
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims description 13
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N 1,2-diethylbenzene Chemical compound CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- AUHZEENZYGFFBQ-UHFFFAOYSA-N 1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 claims description 6
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 6
- OCKPCBLVNKHBMX-UHFFFAOYSA-N butylbenzene Chemical compound CCCCC1=CC=CC=C1 OCKPCBLVNKHBMX-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical compound CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 claims description 6
- 239000008096 xylene Substances 0.000 claims description 6
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- 150000002170 ethers Chemical class 0.000 claims description 5
- MCULRUJILOGHCJ-UHFFFAOYSA-N triisobutylaluminium Chemical compound CC(C)C[Al](CC(C)C)CC(C)C MCULRUJILOGHCJ-UHFFFAOYSA-N 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- JADSGOFBFPTCHG-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)ethanol Chemical compound OCCC1=CC=C2OCOC2=C1 JADSGOFBFPTCHG-UHFFFAOYSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- 150000001241 acetals Chemical class 0.000 claims description 3
- 150000003973 alkyl amines Chemical class 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 150000002790 naphthalenes Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000012071 phase Substances 0.000 description 8
- 0 CCC1=CC=C([1*]O)C([2*]O)=C1 Chemical compound CCC1=CC=C([1*]O)C([2*]O)=C1 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 6
- WUAXWQRULBZETB-UHFFFAOYSA-N homoveratric acid Chemical compound COC1=CC=C(CC(O)=O)C=C1OC WUAXWQRULBZETB-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 238000010626 work up procedure Methods 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Chemical class 0.000 description 4
- 230000020335 dealkylation Effects 0.000 description 4
- 238000006900 dealkylation reaction Methods 0.000 description 4
- 230000017858 demethylation Effects 0.000 description 4
- 238000010520 demethylation reaction Methods 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ODVLMCWNGKLROU-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)acetic acid Chemical compound OC(=O)CC1=CC=C2OCOC2=C1 ODVLMCWNGKLROU-UHFFFAOYSA-N 0.000 description 3
- LWTJEJCZJFZKEL-UHFFFAOYSA-N 2-chloro-3',4'-dihydroxyacetophenone Chemical compound OC1=CC=C(C(=O)CCl)C=C1O LWTJEJCZJFZKEL-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 241000207836 Olea <angiosperm> Species 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 3
- UGFILLIGHGZLHE-UHFFFAOYSA-N methyl 2-(3,4-dihydroxyphenyl)acetate Chemical compound COC(=O)CC1=CC=C(O)C(O)=C1 UGFILLIGHGZLHE-UHFFFAOYSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 150000008378 aryl ethers Chemical class 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- DILOFCBIBDMHAY-UHFFFAOYSA-N methyl 2-(3,4-dimethoxyphenyl)acetate Chemical compound COC(=O)CC1=CC=C(OC)C(OC)=C1 DILOFCBIBDMHAY-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000005949 ozonolysis reaction Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 239000010970 precious metal Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000010517 secondary reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 235000004330 tyrosol Nutrition 0.000 description 2
- RTWOAVKBRMACKZ-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)ethanol Chemical compound COC1=CC=C(C(C)O)C=C1OC RTWOAVKBRMACKZ-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- SRQAJMUHZROVHW-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)ethanol Chemical compound COC1=CC=C(CCO)C=C1OC SRQAJMUHZROVHW-UHFFFAOYSA-N 0.000 description 1
- CJNZAXGUTKBIHP-UHFFFAOYSA-N 2-iodobenzoic acid Chemical class OC(=O)C1=CC=CC=C1I CJNZAXGUTKBIHP-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- RGHMISIYKIHAJW-UHFFFAOYSA-N 3,4-dihydroxymandelic acid Chemical compound OC(=O)C(O)C1=CC=C(O)C(O)=C1 RGHMISIYKIHAJW-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000001412 Mediterranean diet Nutrition 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical class C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical class C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000000861 pro-apoptotic effect Effects 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000006894 reductive elimination reaction Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
- C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
Definitions
- the invention relates to a process for the preparation of hydroxytyrosol (3,4-dihydroxyphenylethanol).
- Hydroxytyrosol is an effective antioxidant and has aroused great interest in recent years on account of its positive effects for health. Hydroxytyrosol is an active component of the Mediterranean diet. The European Food Safety Authority (EFSA) has verified polyphenols from olives as having a positive Health Claim, with a daily hydroxytyrosol dose of at least 5 mg being recommended. An antiinflammatory effect of hydroxytyrosol has also been described. Moreover, there are studies which show that hydroxytyrosol in vitro has antimicrobial properties against pathogens of the respiratory tract and of the gastrointestinal tract, such as against some strains of the genus Vibrio, Salmonella or Staphylococcus and that the dosage used can definitely compete with those of antibiotics, e.g.
- ampicillin Moreover, the substance is attributed a neuroprotective and an anti-proliferative and pro-apoptotic effect. These properties make hydroxytyrosol a very interesting and much researched substance which is used in pharmaceuticals, food supplements, functional foods and also in cosmetics.
- Hydroxytyrosol which has hitherto been available in the market originates for the large part from olives, olive leaves or wastewater which is produced during the production of olive oil and is supplied in the form of an extract.
- the proportion of hydroxytyrosol in these products is very small in most cases. Examples thereof are HIDROXTM with a hydroxytyrosol content below 12%, or OPEXTANTM which contains about 4.5% hydroxytyrosol.
- WO 2008/107109 describes a process for the preparation, by reduction, of 4-(chloroacetyl)-1,2-dihydroxybenzene(4-(chloroacetyl)catechol) with the help of catalysts such as palladium/carbon.
- catalysts such as palladium/carbon.
- the preparation of the starting compound 4-(chloroacetyl)catechol requires high temperatures and long reaction times.
- WO 2007/009590 A1 describes a process for the preparation of hydroxytyrosol via 3,4-dihydroxymandelic acid, which is hydrogenated by metal catalysts such as palladium/carbon to give 3,4-dihydroxyphenylacetic acid. Subsequently, the reduction to hydroxytyrosol takes place. According to the examples, the hydroxytyrosol obtained has purities between 67.9% and 93.8%. Apart from one example, which describes a product with a purity of 98% without stating the pure yield by recrystallization, the precursor obtained from 3,4-dihydroxymandelic acid ester, methyl 3,4-dihydroxyphenyl acetate, is described as product with purities between 51.2% and 83.5%.
- KR 2007 038702 A describes a synthesis via styrene oxide derivatives.
- the starting substance is hydrogenated in the presence of a precious metal catalyst such as palladium on activated carbon.
- Epoxides are unacceptable as regards a mutagenic or carcinogenic effect, meaning that traces in the end product are problematic for use in the food sector.
- esters or acid analogs of hydroxytyrosol are reduced.
- precious metal catalysts or toxic catalysts such as nickel are required for this purpose.
- WO 2008/110908 A1 describes a process starting from tyrosol.
- the process firstly the hydroxyethyl group is protected by means of different reagents, and then a second hydroxy group is inserted into the aromatic ring in the hydroxyethyl-protected tyrosol derivatives using derivatives of iodobenzoic acid.
- Both the starting material tyrosol and the oxidizing agents are very expensive compounds.
- the reaction is complex on account of the many feed materials. There are no details relating to the purity of the hydroxytyrosols obtained by the different processes.
- WO 2009/153374 describes a preparation process starting from safrole. Both safrole and the HMPT used in the reaction are carcinogenic, meaning that this process is unsuitable for producing food supplements on account of the possible impurities.
- WO 2012/003625 describes the preparation of hydroxytyrosol by ozonolysis of eugenol at low temperature and subsequent reduction of the resulting product.
- the demethylation then takes place with the help of a Lewis acid and a mercaptan.
- the low-temperature ozonolysis is an expensive reaction step in which secondary reactions such as oxidation of the phenolic group cannot be excluded.
- the demethylation with the help of extremely foul-smelling substances such as mercaptans which moreover is not easy, makes the preparation of products for use as food supplements difficult. Both reaction steps evidently produce contaminated products, which are described as red oil.
- WO 2012/006783 A1 describes the preparation of hydroxytyrosol starting from low cost pyrocatechol which, following protection of the phenolic groups, is halogenated.
- the halogenated protected pyrocatechol is then reacted with magnesium to give the corresponding Grignard compound, which is reacted with ethylene oxide in order to introduce the hydroxyethyl group into the aromatic ring.
- the demethylation takes place in turn with the help of ethanethiol (ethyl mercaptan) aluminum chloride or hydrogenolysis of benzyl ethers with the help of Pd/C and H 2 .
- the abstract for CN102344344 describes a process in which 3,4-dialkoxyphenylacetic acid alkyl ester (alkyl C1-C5 and benzyl) are reduced and demethylated in one step with the help of sodium in alcohols.
- the advantage of the process is the one-pot reaction, although it is known that the cleavage of aryl ethers with the help of sodium in alcohols is associated with considerable byproduct formation since a cleavage of the aryl ether between oxygen and aromatic ring also arises.
- the yield is at most 50%.
- purification by column chromatography is required.
- R 1 and R 2 are identical or different and are alkyl radical having 1 to 8 carbon atoms, benzyl radical, alkyl- or halogen-substituted benzyl radical or arylalkyl radical, where R 1 and R 2 can also be linked via
- R 2 , R 4 , R 5 and R 6 are identical or different and are hydrogen or alkyl radical having 1 to 6 carbon atoms, aryl radical, alkyl-substituted aryl radical,
- R 5 and R 6 can also be linked via —(CH 2 ) 4 —, —(CH 2 ) 6 — or —(CH 2 ) 6 — to give a ring,
- R 7 , R 8 and R 9 are identical or different and are H or alkyl radical having 1 to 8 carbon atoms, and then an aqueous solution of a hydroxycarboxylic acid is added in an amount such that a clear homogeneous acidic solution with
- hydroxytyrosol is extracted from this aqueous clear homogeneous acidic solution with the help of an organic solvent and the organic solvent is removed.
- X is CH 2 OH.
- R 1 , R 2 are identical or different and are alkyl radical having 1 or 2 carbon atoms.
- the alkyl-substituted benzyl radical is preferably a benzyl radical substituted with a methyl radical in position 2, 3 or 4.
- the arylalkyl radical is for example a phenylethyl radical, phenylpropyl radical, tolylethyl radical.
- R 3 , R 4 , R 5 and R 6 are identical or different and are hydrogen or alkyl radical having 1 or 2 carbon atoms.
- the alkyl-substituted aryl radical is preferably substituted with a methyl radical in position 2, 3 or 4.
- the arylalkyl radical is, for example, a phenylethyl radical, phenylpropyl radical, tolylethyl radical.
- the compound of the formula (1) is preferably a compound selected from the group 2-(3,4-dialkoxy)phenylethanol, 2-(3,4-methylenedioxyphenyl)ethanol, 2-(2,2-dialkylbenzo[1,3]-dioxol-5-yl)ethanol, 2,3-dihydro-1,4-benzodioxin-6-yl)ethanol, and the salts of the aforementioned alcohols.
- It is particularly preferably 2-(3,4-dimethoxy)phenylethanol or 2-(3,4-methylenedioxyphenyl)ethanol.
- the compound of the formula (2) is preferably diisobutylaluminum hydride or triisobutylaluminum.
- the reaction preferably takes place at a temperature between 0° and 200° C., based on a pressure of 1013 hPa, particularly preferably between 20° and 170° C., based on a pressure of 1013 hPa.
- the reaction preferably takes place over a period of 1 to 25 hours, particularly preferably over a period of 5 to 20 hours.
- the compounds of the formula (1) and the compounds of the formula (2) are used in a molar ratio of compound of formula (1): compound of formula (2) of 1:3 to 1:6. Preferably 1:3 to 1:4. If the compound of the formula (1) is used in deficit, i.e. less than 1:3 mol of the compound 1, based on 1 mol of compound 2, then the reaction products formed are only the two monoethers of hydroxytyrosol (2-(3-hydroxy-4-alkoxy)phenylethanol and 2-(4-hydroxy-3-alkoxy)phenylethanol, and the unreacted diether (2-(3,4-dialkoxy)phenylethanol).
- the reaction of the compound of the formula (1) with an aluminum compound of the formula (2) preferably takes place in an organic solvent.
- Suitable solvents for the reaction are aliphatic or aromatic hydrocarbons, which may be linear, branched or cyclic. It is preferably an aromatic hydrocarbon.
- toluene xylene (all isomers), ethylbenzene, diethylbenzene (all isomers), 1,3,5-trimethylbenzene, propylbenzene, isopropylbenzene (cumene), butylbenzene or cyclic alkylbenzenes such as indane, C 1 or C 2 alkylnaphthalenes or partially hydrogenated naphthalenes such as e.g. tetralin.
- Part of the process according to the invention is a simple work-up process of the resulting reaction mixture which makes do without complex purification steps and leads directly to pure hydroxytyrosol.
- the hydroxytyrosol can then be extracted from the aqueous acid phase virtually quantitatively in the usual manner with the help of an organic extractant.
- the reaction mixture is preferably admixed with an aqueous solution of a hydroxycarboxylic acid.
- the aqueous solution of a hydrocarboxylic acid is preferably an aqueous solution of citric acid, malic acid, lactic acid, glycolic acid or tartaric acid.
- the aqueous solution comprises hydroxycarboxylic acid in a concentration of 5 to 50% (v/v).
- the hydroxytyrosol is then extracted from the aqueous phase using an organic solvent. As a result, the aluminum salts are separated off from the hydroxytyrosol.
- the extractant is preferably ethers, carboxylic acid esters, carboxylic acid amides, acetals, ketals, alcohols or alkylamines. Preference is given to ethers or carboxylic acid esters.
- carboxylic acid esters such as ethyl acetate, methyl acetate, isopropyl acetate, particularly preferably ethyl acetate.
- hydroxytyrosol is obtained in high yields, which are understood to mean preferably yields >80%, particularly preferably yields >90%, and in high purity.
- Compounds of the formula (1) are commercially available or can be prepared by customary reduction processes from standard commercial raw materials such as 2-(3,4-methylenedioxyphenyl)acetic acid, 2-(3,4-dimethoxyphenyl)acetic acid, and alkyl esters thereof (alkyl C1-C4 also branched), and benzyl esters.
- the compounds of the formula (1) can also be generated in situ and be further reacted immediately to give hydroxytyrosol.
- those of the formula (3) are used,
- R 1 and R 2 have the meaning given for compounds of the formula (1) and R 10 is H, C 1 to C 4 alkyl radical, benzyl radical, preferably H, methyl radical, ethyl radical.
- the compounds of the formula (3) are preferably 2-(3,4-dialkoxy)phenylacetic acid, 2-(3,4-methylenedioxyphenyl)acetic acid, 2-(2-alkylbenzo[1.3]-dioxol-5-yl)acetic acid, 2,3-dihydro-1,4-benzodioxin-6-yl)acetic acid, and C 1 to C 4 alkyl or benzyl esters of the aforementioned acids.
- Reduction and dealkylation take place here either in one step with compounds of formula (2), where at least one of the radicals (R 7 , R 8 or R 9 ) is H, such as e.g. diisobutylaluminum hydride, or with two different reagents sequentially in a one-pot process.
- the reduction step takes place initially with reducing agents such as e.g. lithium aluminum hydride, sodium borohydride, diisobutylaluminum hydride, alkoxyaluminates such as sodium bis(2-methoxyethoxy)aluminum dihydride to give the compounds of the formula (1), and dealkylation takes place as described for compounds of the formula (1) with a compound of the formula (2).
- Reduction and dealkylation can take place in the same solvent, although the reduction can also take place in a different solvent to the dealkylation, with solvent exchange being possible without isolation of the substance of the formula (1) or salts thereof obtained as an intermediate.
- the solvents already mentioned for the process according to the invention are preferably used; in the second-mentioned case solvents such as ethers, e.g. diethyl ether, diisopropyl ether, dibutyl ether, 1,2-dimethoxyethane, also cyclic such as e.g. tetrahydrofuran, methyltetrahydrofuran, are used. Further work-up takes place as already described.
- high yield is preferably to be understood as meaning a yield of >80%, preferably >90%.
- All of the materials preferably used in the process are commercially available at any time at low cost; of particular advantage is the use of the commercially inexpensively available starting materials, 2-(3,4-dimethoxyphenyl)acetic acid, and also of the esters of 2-(3,4-dimethoxyphenyl)acetic acid and their reaction in one synthesis step to give hydroxytyrosol.
- reaction mixture is introduced into 256 g of 41.8% strength aqueous citric acid solution.
- the organic phase is discarded and the aqueous phase is extracted with 150 g of pentane and then several times with ethyl acetate.
- the pentane phase is discarded and the ethyl acetate phases are combined and washed with 50 g of phosphate buffer pH 7, and the ethyl acetate is removed by distillation. Yield 19.5 g of hydroxytyrosol, 92% of theory
- the xylene phase is discarded and the aqueous phase is extracted once with pentane and three times with 50 ml of ethyl acetate each time.
- the pentane phase is discarded, the ethyl acetate extracts are combined and the ethyl acetate is removed in vacuo. This gives 2.95 g (88% of theory) of hydroxytyrosol as clear colorless oil.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
- The invention relates to a process for the preparation of hydroxytyrosol (3,4-dihydroxyphenylethanol).
- Hydroxytyrosol is an effective antioxidant and has aroused great interest in recent years on account of its positive effects for health. Hydroxytyrosol is an active component of the Mediterranean diet. The European Food Safety Authority (EFSA) has verified polyphenols from olives as having a positive Health Claim, with a daily hydroxytyrosol dose of at least 5 mg being recommended. An antiinflammatory effect of hydroxytyrosol has also been described. Moreover, there are studies which show that hydroxytyrosol in vitro has antimicrobial properties against pathogens of the respiratory tract and of the gastrointestinal tract, such as against some strains of the genus Vibrio, Salmonella or Staphylococcus and that the dosage used can definitely compete with those of antibiotics, e.g. ampicillin. Moreover, the substance is attributed a neuroprotective and an anti-proliferative and pro-apoptotic effect. These properties make hydroxytyrosol a very interesting and much researched substance which is used in pharmaceuticals, food supplements, functional foods and also in cosmetics.
- Hydroxytyrosol which has hitherto been available in the market originates for the large part from olives, olive leaves or wastewater which is produced during the production of olive oil and is supplied in the form of an extract. The proportion of hydroxytyrosol in these products is very small in most cases. Examples thereof are HIDROX™ with a hydroxytyrosol content below 12%, or OPEXTAN™ which contains about 4.5% hydroxytyrosol.
- Besides the isolation of natural hydroxytyrosol from olives, numerous processes are described for preparing this substance synthetically. For example, WO 2008/107109 describes a process for the preparation, by reduction, of 4-(chloroacetyl)-1,2-dihydroxybenzene(4-(chloroacetyl)catechol) with the help of catalysts such as palladium/carbon. However, the preparation of the starting compound 4-(chloroacetyl)catechol requires high temperatures and long reaction times.
- WO 2007/009590 A1 describes a process for the preparation of hydroxytyrosol via 3,4-dihydroxymandelic acid, which is hydrogenated by metal catalysts such as palladium/carbon to give 3,4-dihydroxyphenylacetic acid. Subsequently, the reduction to hydroxytyrosol takes place. According to the examples, the hydroxytyrosol obtained has purities between 67.9% and 93.8%. Apart from one example, which describes a product with a purity of 98% without stating the pure yield by recrystallization, the precursor obtained from 3,4-dihydroxymandelic acid ester, methyl 3,4-dihydroxyphenyl acetate, is described as product with purities between 51.2% and 83.5%.
- The abstract for KR 2007 038702 A describes a synthesis via styrene oxide derivatives. The starting substance is hydrogenated in the presence of a precious metal catalyst such as palladium on activated carbon. Epoxides are unacceptable as regards a mutagenic or carcinogenic effect, meaning that traces in the end product are problematic for use in the food sector.
- In the specified hydrogenation reaction, esters or acid analogs of hydroxytyrosol are reduced. Disadvantageously, precious metal catalysts or toxic catalysts such as nickel are required for this purpose.
- WO 2008/110908 A1 describes a process starting from tyrosol. In the process, firstly the hydroxyethyl group is protected by means of different reagents, and then a second hydroxy group is inserted into the aromatic ring in the hydroxyethyl-protected tyrosol derivatives using derivatives of iodobenzoic acid. Both the starting material tyrosol and the oxidizing agents are very expensive compounds. The reaction is complex on account of the many feed materials. There are no details relating to the purity of the hydroxytyrosols obtained by the different processes.
- WO 2009/153374 describes a preparation process starting from safrole. Both safrole and the HMPT used in the reaction are carcinogenic, meaning that this process is unsuitable for producing food supplements on account of the possible impurities.
- WO 2012/003625 describes the preparation of hydroxytyrosol by ozonolysis of eugenol at low temperature and subsequent reduction of the resulting product. The demethylation then takes place with the help of a Lewis acid and a mercaptan. The low-temperature ozonolysis is an expensive reaction step in which secondary reactions such as oxidation of the phenolic group cannot be excluded. The demethylation with the help of extremely foul-smelling substances such as mercaptans, which moreover is not easy, makes the preparation of products for use as food supplements difficult. Both reaction steps evidently produce contaminated products, which are described as red oil.
- WO 2012/006783 A1 describes the preparation of hydroxytyrosol starting from low cost pyrocatechol which, following protection of the phenolic groups, is halogenated. The halogenated protected pyrocatechol is then reacted with magnesium to give the corresponding Grignard compound, which is reacted with ethylene oxide in order to introduce the hydroxyethyl group into the aromatic ring. The demethylation takes place in turn with the help of ethanethiol (ethyl mercaptan) aluminum chloride or hydrogenolysis of benzyl ethers with the help of Pd/C and H2.
- For all three described processes there is considerable purification complexity for each of the three stages. Moreover, the ethoxylation takes place with a considerable excess of ethylene oxide; a formation of oligomeric glycol units is therefore probable. Depending on the protective group, the demethylation takes place by Lewis acid and ethylmercaptan, with the problems already described, or by hydrogenolysis. The yields of hydroxytyrosol are 32% to 70% in the three described processes. The products obtained are yellow to red oils, which suggests considerable impurities. Possible impurities due to traces of carcinogenic ethylene oxide are problematic for use in the food supplement sector.
- The abstract for CN102344344 describes a process in which 3,4-dialkoxyphenylacetic acid alkyl ester (alkyl C1-C5 and benzyl) are reduced and demethylated in one step with the help of sodium in alcohols. The advantage of the process is the one-pot reaction, although it is known that the cleavage of aryl ethers with the help of sodium in alcohols is associated with considerable byproduct formation since a cleavage of the aryl ether between oxygen and aromatic ring also arises. In the examples, the yield is at most 50%. In all of the examples, purification by column chromatography is required.
- The abstract for CN101891595 describes a very complex four-stage process for the preparation of hydroxytyrosol with unknown purification complexity and impurities.
- The reductive cleavage of 2,2-dialkyl-1,3-benzodioxole derivatives with the help of diisobutylaluminum hydride is described by G. Schill et al.; Chem. Ber. 113, 3697-3705, 1980. For the cleavage of the catechol acetals, a more than 13-fold amount of diisobutylaluminum hydride is used in the molar ratio.
- A. Gambacorta, D. Tofani, A. Migliorini; Molecules 2007, 12, 1762-1770 describe a three-stage hydroxytyrosol synthesis which starts from methyl 3,4-dihydroxyphenylacetate. The process is complex and methyl 3,4-dihydroxyphenylacetate is not a standard commercial substance and, according to this literature reference, has to itself be prepared in a multistage process.
- It was an object of the present invention to provide an effective and low cost process which makes it possible to prepare hydroxytyrosol easily and in high purity.
- This object is achieved by a process in which a compound of the general formula (1)
- where X is CH2OH or CH2OM (M=Li, Na, K, Mg, Ca),
- R1 and R2 are identical or different and are alkyl radical having 1 to 8 carbon atoms, benzyl radical, alkyl- or halogen-substituted benzyl radical or arylalkyl radical, where R1 and R2 can also be linked via
- to give a ring,
- R2, R4, R5 and R6 are identical or different and are hydrogen or alkyl radical having 1 to 6 carbon atoms, aryl radical, alkyl-substituted aryl radical,
- where R5 and R6 can also be linked via —(CH2)4—, —(CH2)6— or —(CH2)6— to give a ring,
- is reacted with an aluminum compound of the formula (2) AlR7R8R9 (2)
- where R7, R8 and R9 are identical or different and are H or alkyl radical having 1 to 8 carbon atoms, and then an aqueous solution of a hydroxycarboxylic acid is added in an amount such that a clear homogeneous acidic solution with
- a pH<3 is formed,
- hydroxytyrosol is extracted from this aqueous clear homogeneous acidic solution with the help of an organic solvent and the organic solvent is removed.
- In the process according to the invention, reducing conditions prevail during the entire reaction. Consequently, an oxidation of the sensitive hydroxytyrosol cannot arise.
- Furthermore, under these conditions no secondary reactions take place, such as elimination of water from the 2-phenylethanol group. The hydroxytyrosol obtained from this process is a colorless clear liquid.
- Preferably, X is CH2OH.
- Preferably, R1, R2 are identical or different and are alkyl radical having 1 or 2 carbon atoms.
- The alkyl-substituted benzyl radical is preferably a benzyl radical substituted with a methyl radical in position 2, 3 or 4.
- The arylalkyl radical is for example a phenylethyl radical, phenylpropyl radical, tolylethyl radical.
- Preferably, R3, R4, R5 and R6 are identical or different and are hydrogen or alkyl radical having 1 or 2 carbon atoms.
- The alkyl-substituted aryl radical is preferably substituted with a methyl radical in position 2, 3 or 4.
- The arylalkyl radical is, for example, a phenylethyl radical, phenylpropyl radical, tolylethyl radical.
- The compound of the formula (1) is preferably a compound selected from the group 2-(3,4-dialkoxy)phenylethanol, 2-(3,4-methylenedioxyphenyl)ethanol, 2-(2,2-dialkylbenzo[1,3]-dioxol-5-yl)ethanol, 2,3-dihydro-1,4-benzodioxin-6-yl)ethanol, and the salts of the aforementioned alcohols.
- It is particularly preferably 2-(3,4-dimethoxy)phenylethanol or 2-(3,4-methylenedioxyphenyl)ethanol.
- The compound of the formula (2) is preferably diisobutylaluminum hydride or triisobutylaluminum.
- The reaction preferably takes place at a temperature between 0° and 200° C., based on a pressure of 1013 hPa, particularly preferably between 20° and 170° C., based on a pressure of 1013 hPa.
- The reaction preferably takes place over a period of 1 to 25 hours, particularly preferably over a period of 5 to 20 hours.
- Preferably, the compounds of the formula (1) and the compounds of the formula (2) are used in a molar ratio of compound of formula (1): compound of formula (2) of 1:3 to 1:6. Preferably 1:3 to 1:4. If the compound of the formula (1) is used in deficit, i.e. less than 1:3 mol of the compound 1, based on 1 mol of compound 2, then the reaction products formed are only the two monoethers of hydroxytyrosol (2-(3-hydroxy-4-alkoxy)phenylethanol and 2-(4-hydroxy-3-alkoxy)phenylethanol, and the unreacted diether (2-(3,4-dialkoxy)phenylethanol). When reacting (2-(3,4-dimethoxy)phenylethanol), the byproducts formed are only 2-(3-hydroxy-4-methoxy)phenylethanol and 2-(4-hydroxy-3-methoxy)phenylethanol. These compounds are also present in natural olive extracts or natural olive oil and occur as metabolites of hydroxytyrosol.
- The reaction of the compound of the formula (1) with an aluminum compound of the formula (2) preferably takes place in an organic solvent. Suitable solvents for the reaction are aliphatic or aromatic hydrocarbons, which may be linear, branched or cyclic. It is preferably an aromatic hydrocarbon. Particular preference is given to toluene, xylene (all isomers), ethylbenzene, diethylbenzene (all isomers), 1,3,5-trimethylbenzene, propylbenzene, isopropylbenzene (cumene), butylbenzene or cyclic alkylbenzenes such as indane, C1 or C2 alkylnaphthalenes or partially hydrogenated naphthalenes such as e.g. tetralin.
- Part of the process according to the invention is a simple work-up process of the resulting reaction mixture which makes do without complex purification steps and leads directly to pure hydroxytyrosol. Surprisingly, it has been found that upon work-up of the resulting reaction mixture with the help of an aqueous solution of a hydroxycarboxylic acid, the hydroxytyrosol can then be extracted from the aqueous acid phase virtually quantitatively in the usual manner with the help of an organic extractant.
- Firstly, when the reaction is complete, the reaction mixture is preferably admixed with an aqueous solution of a hydroxycarboxylic acid.
- The aqueous solution of a hydrocarboxylic acid is preferably an aqueous solution of citric acid, malic acid, lactic acid, glycolic acid or tartaric acid.
- Preferably, the aqueous solution comprises hydroxycarboxylic acid in a concentration of 5 to 50% (v/v).
- What happens here is that the hydroxytyrosol transfers from the organic phase to the aqueous phase, with hydrophobic impurities remaining in the organic phase.
- The hydroxytyrosol is then extracted from the aqueous phase using an organic solvent. As a result, the aluminum salts are separated off from the hydroxytyrosol.
- The extractant is preferably ethers, carboxylic acid esters, carboxylic acid amides, acetals, ketals, alcohols or alkylamines. Preference is given to ethers or carboxylic acid esters.
- Of particular suitability here are compounds which form an azeotrope with water which has a boiling point of <100° C., meaning that the water present in the organic phase is removed upon distilling off the solvent.
- Particular preference is given to using carboxylic acid esters such as ethyl acetate, methyl acetate, isopropyl acetate, particularly preferably ethyl acetate.
- After removing the extractant, e.g. by distillation, hydroxytyrosol is obtained in high yields, which are understood to mean preferably yields >80%, particularly preferably yields >90%, and in high purity.
- Compounds of the formula (1) are commercially available or can be prepared by customary reduction processes from standard commercial raw materials such as 2-(3,4-methylenedioxyphenyl)acetic acid, 2-(3,4-dimethoxyphenyl)acetic acid, and alkyl esters thereof (alkyl C1-C4 also branched), and benzyl esters.
- The compounds of the formula (1) can also be generated in situ and be further reacted immediately to give hydroxytyrosol. In this case, in the process according to the invention, instead of compounds of the formula (1), those of the formula (3) are used,
- where X is COOR10,
- R1 and R2 have the meaning given for compounds of the formula (1) and R10 is H, C1 to C4 alkyl radical, benzyl radical, preferably H, methyl radical, ethyl radical.
- The compounds of the formula (3) are preferably 2-(3,4-dialkoxy)phenylacetic acid, 2-(3,4-methylenedioxyphenyl)acetic acid, 2-(2-alkylbenzo[1.3]-dioxol-5-yl)acetic acid, 2,3-dihydro-1,4-benzodioxin-6-yl)acetic acid, and C1 to C4 alkyl or benzyl esters of the aforementioned acids.
- It is particularly preferably 2-(3,4-dialkoxy)phenylacetic acid or their methyl or ethyl esters, and 2-(3,4-methylenedioxyphenyl)acetic acid or their methyl or ethyl esters.
- Reduction and dealkylation take place here either in one step with compounds of formula (2), where at least one of the radicals (R7, R8 or R9) is H, such as e.g. diisobutylaluminum hydride, or with two different reagents sequentially in a one-pot process. In the second-mentioned case, the reduction step takes place initially with reducing agents such as e.g. lithium aluminum hydride, sodium borohydride, diisobutylaluminum hydride, alkoxyaluminates such as sodium bis(2-methoxyethoxy)aluminum dihydride to give the compounds of the formula (1), and dealkylation takes place as described for compounds of the formula (1) with a compound of the formula (2).
- Reduction and dealkylation can take place in the same solvent, although the reduction can also take place in a different solvent to the dealkylation, with solvent exchange being possible without isolation of the substance of the formula (1) or salts thereof obtained as an intermediate. In the first-mentioned case, the solvents already mentioned for the process according to the invention are preferably used; in the second-mentioned case solvents such as ethers, e.g. diethyl ether, diisopropyl ether, dibutyl ether, 1,2-dimethoxyethane, also cyclic such as e.g. tetrahydrofuran, methyltetrahydrofuran, are used. Further work-up takes place as already described.
- The process according to the invention produces a high yield of isolated hydroxytyrosol with a small number of synthesis steps. In this connection, high yield is preferably to be understood as meaning a yield of >80%, preferably >90%.
- All of the materials preferably used in the process are commercially available at any time at low cost; of particular advantage is the use of the commercially inexpensively available starting materials, 2-(3,4-dimethoxyphenyl)acetic acid, and also of the esters of 2-(3,4-dimethoxyphenyl)acetic acid and their reaction in one synthesis step to give hydroxytyrosol.
- The following examples serve to further describe the invention.
- a) The compounds of formula (1) are used as such
- In an apparatus with three-neck flask, stirrer, internal thermometer, metering funnel, reflux condenser and inert gas connection, 25 g (137 mmol) of 2-(3,4-dimethoxyphenyl)ethanol are suspended in 56 g of cumene and heated to reflux temperature, with 481 g of a 21% strength triisobutylaluminum solution in cumene being metered in over the course of 6 hours. The reaction mixture is heated under reflux for a total of 14 h.
- After cooling, the reaction mixture is introduced into 256 g of 41.8% strength aqueous citric acid solution. The organic phase is discarded and the aqueous phase is extracted with 150 g of pentane and then several times with ethyl acetate. The pentane phase is discarded and the ethyl acetate phases are combined and washed with 50 g of phosphate buffer pH 7, and the ethyl acetate is removed by distillation. Yield 19.5 g of hydroxytyrosol, 92% of theory
- 5 g (27.4 mmol) of 3,4-dimethoxyphenylethanol are suspended in 13 ml of cumene, and 79 g of 21% strength (=116 mmol) diisobutylaluminum hydride solution in cumene are metered in with cooling (temp. <30° C.) over 20 min, giving a clear solution. The reaction mixture is heated at 150° C. for 5 h. A sample collection reveals a conversion of 91.8%. After a further 3.5 h at 150° C., the mixture is left to cool and the mixture is added, with ice cooling, to 59 g of 40% strength aqueous citric acid solution. The phases are separated, the organic phase is discarded and the aqueous phase is washed with 30 ml of pentane. The pentane phase is discarded and the aqueous phase is then extracted 4 times with 50 ml of ethyl acetate. The ethyl acetate phases are combined and washed once with 30 g of water. The ethyl acetate is then removed by distillation. Yield: 3.85 g of 91.1% hydroxytyrosol
- b) The compounds of formula (1) are produced in situ from compounds of formula (3)
- In an apparatus with three-necked flask, stirrer, internal thermometer, metering funnel, reflux condenser and inert gas connection, 4.0 g (19 mmol) of methyl 2-(3,4-dimethoxyphenyl)acetate are dissolved in 4 g of xylene, and 13.5 g (95 mmol) of diisobutylaluminum hydride dissolved in 40.5 g of xylene are metered in. When the addition is complete, the reaction mixture is heated to reflux. After reflux for 20 h, the mixture is left to cool and is admixed, with cooling, with 105 g of 20% strength citric acid solution. The xylene phase is discarded and the aqueous phase is extracted once with pentane and three times with 50 ml of ethyl acetate each time. The pentane phase is discarded, the ethyl acetate extracts are combined and the ethyl acetate is removed in vacuo. This gives 2.95 g (88% of theory) of hydroxytyrosol as clear colorless oil.
- The procedure takes place analogously to example 3 except that the solvent used is diethylbenzene and the reaction temperature is 160° C. After 4 h, the mixture is worked up as described under example 3. Yield: 2.8 g (93%) of hydroxytyrosol as clear colorless oil.
- 2.1 g (10 mmol) of methyl 2-(3,4-dimethoxyphenyl)acetate are dissolved in 30 ml of toluene, and 10 ml of a 1M solution of the lithiumaluminum hydride-tetrahydrofuran complex in toluene are added. After reaction for 1.5 h from 38° C. to 50° C., the reaction mixture is admixed with 40 ml of diethylbenzene, and tetrahydrofuran and toluene are distilled off until the boiling temperature of 150° C. is reached. After cooling, 18 g of a 30% strength solution of diisobutylaluminum hydride in diethylbenzene are added and the reaction mixture is then heated at 150° C. for 5.5 h. Work-up takes place as described in example 3. Yield 82%
- The procedure takes place analogously to example 3 except that work-up was with 5% strength hydrochloric acid instead of with citric acid solution. The aqueous phase forms an opaque gel, from which no hydroxytyrosol can be isolated.
Claims (18)
AlR2R8R9 (2)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102013203753.8 | 2013-03-05 | ||
| DE102013203753.8A DE102013203753A1 (en) | 2013-03-05 | 2013-03-05 | Process for the preparation of hydroxytyrosol |
| DE102013203753 | 2013-03-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US8822738B1 US8822738B1 (en) | 2014-09-02 |
| US20140256989A1 true US20140256989A1 (en) | 2014-09-11 |
Family
ID=50115734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/188,837 Active US8822738B1 (en) | 2013-03-05 | 2014-02-25 | Process for the preparation of hydroxytyrosol |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8822738B1 (en) |
| EP (1) | EP2774909B1 (en) |
| JP (1) | JP5702871B2 (en) |
| KR (1) | KR101599818B1 (en) |
| CN (1) | CN104030894B (en) |
| DE (1) | DE102013203753A1 (en) |
| ES (1) | ES2552176T3 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3706759B1 (en) * | 2017-11-08 | 2023-11-15 | Société des Produits Nestlé S.A. | Homovanillyl alcohol (hva), hva isomer, methods of making compositions comprising such compounds, and methods using such compounds |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106866384B (en) * | 2016-12-29 | 2020-11-06 | 陕西嘉禾药业有限公司 | Preparation method of hydroxytyrosol |
| DE102020132795B4 (en) | 2020-12-09 | 2025-02-13 | Technische Universität Bergakademie Freiberg, Körperschaft des öffentlichen Rechts | Process for the biotechnological production of 2-phenylethanols from plant sources |
| JP7757412B2 (en) | 2021-03-03 | 2025-10-21 | ワッカー ケミー アクチエンゲゼルシャフト | Hydroxytyrosol manufacturing method |
| CN113264814B (en) * | 2021-06-10 | 2022-07-26 | 南京斯贝源医药科技有限公司 | Process for preparing hydroxytyrosol |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8017815B2 (en) * | 2007-03-07 | 2011-09-13 | Dsm Ip Assets B.V. | Process for the preparation of hydroxytyrosol |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1502635A (en) * | 1974-02-27 | 1978-03-01 | Schering Ag | Process for splitting steroid ethers |
| US7713569B2 (en) * | 2000-09-01 | 2010-05-11 | Creagri, Inc. | Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| WO2007009590A1 (en) | 2005-07-18 | 2007-01-25 | Dsm Ip Assets B.V. | Process for the preparation of phenolic compounds |
| KR20070038702A (en) | 2005-10-06 | 2007-04-11 | 위드팔켐 주식회사 | Method for preparing hydroxytyrosol |
| ITMI20070519A1 (en) | 2007-03-15 | 2008-09-16 | Maurizio Barontini | PROCEDURE FOR THE PREPARATION OF HYDROXYSEROSOL AND HYDROXYSEROSOL DERIVATIVES |
| ES2332635B2 (en) | 2008-06-20 | 2010-08-10 | Universidad De Granada | PROCEDURE FOR THE PREPARATION OF HYDROXYTIROSOL AND 3- (3,4-DIHYDROXYPHENYL) PROPANOL FROM METHYLENDIOXIBENGENS. |
| CN101580460B (en) * | 2009-05-26 | 2012-05-23 | 台州市知青化工有限公司 | Synthetic method of 3, 4-dihydroxy phenethyl alcohol |
| WO2012003625A1 (en) | 2010-07-06 | 2012-01-12 | Lonza Ltd | Process for preparing hydroxytyrosol |
| CN106928030A (en) | 2010-07-15 | 2017-07-07 | 广州南沙龙沙有限公司 | The method that hydroxytyrosol is prepared using organo-metallic compound |
| CN101891595B (en) | 2010-07-22 | 2013-05-01 | 苏州大学 | Method for preparing hydroxytyrosol |
| CN102344344B (en) | 2011-11-11 | 2014-12-24 | 西北大学 | Synthesis method of hydroxytyrosol |
-
2013
- 2013-03-05 DE DE102013203753.8A patent/DE102013203753A1/en not_active Withdrawn
-
2014
- 2014-01-28 JP JP2014013462A patent/JP5702871B2/en active Active
- 2014-02-19 EP EP14155738.9A patent/EP2774909B1/en active Active
- 2014-02-19 ES ES14155738.9T patent/ES2552176T3/en active Active
- 2014-02-25 US US14/188,837 patent/US8822738B1/en active Active
- 2014-02-26 KR KR1020140022496A patent/KR101599818B1/en active Active
- 2014-02-27 CN CN201410069820.6A patent/CN104030894B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8017815B2 (en) * | 2007-03-07 | 2011-09-13 | Dsm Ip Assets B.V. | Process for the preparation of hydroxytyrosol |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3706759B1 (en) * | 2017-11-08 | 2023-11-15 | Société des Produits Nestlé S.A. | Homovanillyl alcohol (hva), hva isomer, methods of making compositions comprising such compounds, and methods using such compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014172907A (en) | 2014-09-22 |
| US8822738B1 (en) | 2014-09-02 |
| ES2552176T3 (en) | 2015-11-26 |
| CN104030894A (en) | 2014-09-10 |
| EP2774909A1 (en) | 2014-09-10 |
| CN104030894B (en) | 2016-11-02 |
| KR101599818B1 (en) | 2016-03-14 |
| DE102013203753A1 (en) | 2014-09-11 |
| JP5702871B2 (en) | 2015-04-15 |
| EP2774909B1 (en) | 2015-08-12 |
| KR20140109274A (en) | 2014-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8822738B1 (en) | Process for the preparation of hydroxytyrosol | |
| CN102884035B (en) | Synthesis of magnolol and its analogous compounds | |
| GB0916848D0 (en) | Crystalline compound | |
| Gharpure et al. | o-Quinone methide based approach to isoflavans: application to the total syntheses of equol, 3′-hydroxyequol and vestitol | |
| Rye et al. | Asymmetric synthesis and anti-protozoal activity of the 8, 4′-oxyneolignans virolin, surinamensin and analogues | |
| CN105237411A (en) | Preparation method for sarpogrelate hydrochloride photodegradable impurity III | |
| CN101891595A (en) | A kind of preparation method of hydroxytyrosol | |
| CN106673967B (en) | Preparation method of 4- (2-methallyl) -1, 2-benzenediol | |
| EP2970066A1 (en) | Process for the preparation of 3,7-dimethylnonan-1-ol | |
| JP6686012B2 (en) | Method for preparing halo-substituted trifluoroacetophenone | |
| CN112939920A (en) | Preparation method of dracorhodin A or dracorhodin B | |
| CN101007785B (en) | 2[(3-phenyl) acrylketone]-3-methylquinoxaline chemical synthesis method | |
| KR102083753B1 (en) | Method for manufacturing phosphonocrotonic acid derivative | |
| Kuo et al. | An efficient synthesis of a potent anti-inflammatory agent, viscolin, and its inducible nitric oxide synthase inhibitory activity | |
| CN103254048A (en) | A kind of separation and purification method of isovanillin crude product | |
| Zhang et al. | Synthesis and Antiproliferative In‐Vitro Activity of Natural Flavans and Related Compounds | |
| Lu et al. | Total synthesis of wikstrol A and wikstrol B | |
| KR100932071B1 (en) | Method for preparing benzal acetophenone derivative | |
| EP2404891A1 (en) | Preparation method of acylbenzenes | |
| KR20090091252A (en) | Synthesis method of citrubinin, boesenbergin a, boesenbergin bee, xanthohumol and glabrachromen | |
| CN105237477A (en) | Preparation method for meptazinol impurity C | |
| JP5712580B2 (en) | Process for producing 5,7-dihydroxy-6-methoxyflavones | |
| CN119954620A (en) | A new impurity of dexmedetomidine hydrochloride and preparation method thereof | |
| JP2015007054A (en) | Synthesis of magnolol and its analog compounds. | |
| RU2417214C1 (en) | Method of producing isocamphylphenols |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| AS | Assignment |
Owner name: WACKER CHEMIE AG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KRUEGER, BENNO;FLEISCHMANN, GERALD;PETERSEN, HERMANN;REEL/FRAME:032293/0138 Effective date: 20140214 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551) Year of fee payment: 4 |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |